Silagra (Generic Sildenafil) Online Review
Silagra is a generically produced sildenafil drug used to restore erectile potential. The drug is manufactured by a reputable pharmaceutical company headquartered in India, and has become hugely successful with scores of users internationally over the years of its existence. What is behind the drug’s success? How safe is Silagra? How efficient is the drug? You will find the answer to these and other questions in the paragraphs below.
Sildenafil mechanism of action
Silagra features the very same component as its fancier big brother Viagra in designer clothes. It has none of the fancy cost though, and is therefore available across the economical strata, and this is what prescribers around the world like about it so much. Silagra does exactly the same job, which is blocking the enzyme with a tongue-twisting name of phosphodiesterase type 5 from its morbiferous action in the penile tissues. The blood circulation in the erectile bodies of the penis thus gets restored, and for a period of 4 hours, give or take, a man can achieve wonderfully hard and controllable erections whenever he finds himself in a sexually arousing context.
Is sildenafil citrate from India safe?
It is important to understand the difference between generic and bioequivalent drugs. Bioequivalent medications have similar mechanism of action, but are not identical. But when we talk about generic drugs, it is the very same substance we talk about, like it is the case with sildenafil used in both Viagra and Silagra. Not similar, but just the same, by active ingredient, route of administration, pharmaceutical form and even excipients.
In medicinal practice, it is the active substance that doctors prescribe, not the specific drug. Most commonly, your prescriber will then inform you about the existing competition between the brand drug and its generics; more and more men choose in favor of a generic.
Generic drugs have both global meaning and individual practicality. To take full advantage of generics, the companies that control both the production of the originals and the equivalents must operate in the awareness of their social responsibility. In other words: it is necessary to overcome the conflict of interests between those who produce both categories of drugs and privilege the most expensive with generic analogs.
The company that releases Silagra, Cipla Ltd., is based in India, but has enterprising facilities in other countries, including some European countries. The plant cooperates with the international quality controlling authorities and shows outstanding consistency with the regulatory requirements imposed by such institutions. In particular, they regularly attest their compliance with the Current Good Manufacturing Practice (CGMP), which gives firm grounds to state that the quality of their produce is identical to that of the drugs manufactured by the original developer of sildenafil. This assumption is based on the simple logic that both report to the same authorities complying with the same principles and standards concerning the materials, appliances, technologies and hygiene norms.